Angiotensin-converting enzyme I/D polymorphism and acute respiratory distress syndrome

J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):780-6. doi: 10.1177/1470320315576255. Epub 2015 Apr 12.

Abstract

Background: Some studies have assessed the association between angiotensin-converting enzyme (ACE) I/D polymorphism and acute respiratory distress syndrome (ARDS) risk. However, the results have been inconclusive and contradictory. Therefore, we performed a meta-analysis to investigate the association between ACE I/D polymorphism and ARDS risk.

Methods: All relevant studies were searched using PubMed and EMBASE. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were estimated using random-effects models or fixed-effects models.

Results: A total of 14 studies with 5218 subjects were included in this meta-analysis. We found that ACE I/D polymorphism significantly associated with an increased ARDS risk (OR=1.57; 95% CI 1.30-1.89; P<0.00001). In the subgroup analysis by race, Caucasians with ACE I/D polymorphism showed increased ARDS risk (OR=1.63; 95% CI 1.32-2.02; P<0.00001). However, Asians with this polymorphism did not show significantly increased ARDS risk (OR=1.31; 95% CI 0.90-1.90; P=0.95). In the subgroup analysis by age group, adults showed increased ARDS risk (OR=1.60; 95% CI 1.32-1.93; P<0.00001), while pediatric patients did not have increased ARDS risk (OR=1.15; 95% CI 0.57-2.30; P=0.70).

Conclusions: This meta-analysis suggested that ACE I/D polymorphism might contribute to the susceptibility for ARDS.

Keywords: Angiotensin-converting enzyme; acute respiratory distress syndrome; association study; genetics; polymorphism.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genetic Association Studies
  • Genetic Predisposition to Disease*
  • Humans
  • INDEL Mutation / genetics*
  • Peptidyl-Dipeptidase A / genetics*
  • Polymorphism, Genetic
  • Respiratory Distress Syndrome / enzymology*
  • Respiratory Distress Syndrome / genetics*
  • Risk Factors

Substances

  • ACE protein, human
  • Peptidyl-Dipeptidase A